| Particulars (Rupees in Crores.) | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sept-2023 |
|---|---|---|---|---|---|
Gross Sales | 3,076.51 | 2,893.42 | 2,441.1 | 2,606.96 | 2,708.1 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,076.51 | 2,893.42 | 2,441.1 | 2,606.96 | 2,708.1 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 112 | 104.51 | 94.54 | 74.74 | 63.45 |
Total Income | 3,188.51 | 2,997.93 | 2,535.64 | 2,681.69 | 2,771.55 |
Total Expenditure | 2,226.47 | 2,211.66 | 1,850 | 2,000.45 | 2,025.45 |
PBIDT | 962.04 | 786.27 | 685.64 | 681.24 | 746.1 |
Interest | 7.1 | 10.91 | 9.38 | 9.19 | 8.62 |
PBDT | 954.94 | 775.36 | 676.26 | 672.06 | 737.48 |
Depreciation | 105.62 | 107.74 | 104.69 | 109.73 | 96.49 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 168.13 | 138.7 | 114.52 | 71.2 | 162.09 |
Deferred Tax | 22.31 | -14.15 | -19.54 | 31.31 | -32.28 |
Reported Profit After Tax | 658.88 | 543.07 | 476.59 | 459.81 | 511.18 |
Minority Interest After NP | 5.41 | 6.58 | 5.35 | 6.05 | 10.15 |
Net Profit after Minority Interest | 653.47 | 536.49 | 471.24 | 453.76 | 501.03 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 653.47 | 536.49 | 471.24 | 453.76 | 501.03 |
EPS (Unit Curr.) | 16.31 | 13.39 | 11.76 | 11.33 | 12.51 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 31.27 | 27.17 | 28.08 | 26.13 | 27.55 |
PBDTM(%) | 31.03 | 26.79 | 27.7 | 25.77 | 27.23 |
PATM(%) | 21.41 | 18.76 | 19.52 | 17.63 | 18.87 |
Revenue from operations grew by 13.6% YoY, totaling ₹3,076.5 Crore, up from ₹2,708.1 Crore in Q2 of the previous fiscal.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.
Here are some of the stocks that may see significant price movement today: Escorts Kubota, Infosys, Mahindra & Mahindra, etc.
Mankind announced in July that it would purchase the whole stake in Bharat Serums and Vaccines.
Here are some of the stocks that may see significant price movement today: Suzlon Energy, Aurobindo Pharma, Coal India, etc.
Here are some of the stocks that may see significant price movement today: Tata Power, India Glycols, Jindal Stainless, etc.
The company will offer commercial papers on the BSE in numerous tranches ranging from three to twelve months
This strategic move is intended to streamline Mankind Pharma’s operations, enabling greater focus on its core pharmaceutical business.
The transfer is in line with Mankind Pharma's previously announced strategy on April 2, aiming to enhance operational efficiency by consolidating the OTC business under MCPPL.
When the acquisition was announced, the business stated that it will be paid by internal accruals as well as a combination of debt and stock.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
